3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Waldenstrom Macroglobulinemia
1
Solitary Fibrous Tumor, Pleural
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Clear Cell
1
Chondrosarcoma
1
Cancer Pain
1
Breast Neoplasms
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Adult Patients Who Are Receiving Oncologic Care
1
Adjustment Disorders
1
Interventions
Dexamethasone
13
daratumumab
7
Bortezomib
7
Cyclophosphamide
6
Calcium Dobesilate
5
ixazomib
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
auricularum
4
venetoclax
3
belantamab mafodotin
3
Specimen Handling
3
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
3
pomalidomide
2
isatuximab
2
X-Rays
2
Polymerase Chain Reaction
2
Phantoms, Imaging
2
Magnetic Resonance Spectroscopy
2
Clinical Protocols
2
Biopsy
2
siltuximab
1
Valganciclovir
1
Tissue Banks
1
Therapeutics
1
Stem Cell Transplantation
1
Spectrometry, Fluorescence
1
Positron-Emission Tomography
1
Pharmaceutical Preparations
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Pharmacogenomic Testing
×
1 year
×
Clear all
No trials found.